Purchase Order 36C25621P0360
Award Date 12/16/20
Potential Completion Date 2/16/21
Potential Value $136K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with a ceiling value of $85,242.15, was issued by the Department of Veterans Affairs Veterans Integrated Service Network 16 to Pantherx Specialty, LLC, a specialty pharmacy subsidiary of Centene Corporation. The contract is a firm fixed price purchase order for the supply of the drug Ruzurgi (amifampridine 10mg) to VA facilities within VISN 16. This contract supports the medical needs of veterans obtaining care through the VA health system. No set-aside designation...
- Pantherx Specialty, LLC, a Pittsburgh-based specialty pharmacy and subsidiary of Centene Corporation, was awarded a firm fixed-price purchase order valued at $10,896.98 on December 8, 2025, by the Veterans Integrated Service Network 2 (VISN 2), a civilian component of the Department of Veterans Affairs. The contract covers the emergency procurement of TARPEYO (budesonide) 4mg medication, with an ultimate completion date of January 7, 2026. There was no set-aside designation associated with...
- This is a firm fixed price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company and subsidiary of Centene Corporation. The contract is for the supply of TARPEYO 4MG, a prescription medication, to the New York Harbor VA Medical Center. The contract has a ceiling value of $10,896.98 and an ultimate completion date of June 23, 2025. The contract does...
- This is a federal contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the purchase of TARPEYO 4MG for the New York Harbor, with an ultimate completion date of November 5, 2025 and a ceiling value of $10,896.98. The contract is a firm fixed-price purchase order and does not have a set-aside designation. Pantherx Specialty, LLC is the...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Anovorx Distribution LLC, a small business for-profit limited liability company, to provide the medication Firdapse (Amifampridine). The contract has a potential value of $151,359.02 and a completion date of September 19, 2019. Anovorx Distribution LLC has provided various specialty pharmaceutical products to the VA and Department of the Army Medical Command...
- The Department of Veterans Affairs (VA) awarded a delivery order to Recordati Rare Diseases Inc., a foreign-owned, for-profit manufacturer, to provide the pharmaceutical product FILSPARI 200 MG. The order is placed against Recordati's existing Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA. The firm fixed-price delivery order is valued at $11,280.64 and has a period of performance through March 26, 2024. Recordati Rare Diseases is a key supplier of specialty...
- The Department of Veterans Affairs (VA) Veterans Health Administration and Veterans Integrated Service Network 12 awarded a firm fixed price delivery order contract to Acorda Therapeutics, Inc., a biotechnology company that develops drugs to improve therapies for neurological conditions. The $485,835.00 contract is for the delivery of DALFAMPRIDINE 10MG SA, a pharmaceutical product, with a completion date of July 14, 2017. The contract was issued off of the VA's Pharmaceuticals and Drugs Federal...
- Catalyst Pharmaceuticals, Inc. was awarded a delivery order valued at $18,978.13 by Veterans Integrated Service Network 5 (VISN 5), a civilian agency within the Department of Veterans Affairs, for the supply of Firdapse 10 mg tablets. This contract, effective December 17, 2025, with an ultimate completion date of December 19, 2025, operates under a firm fixed-price model and carries no set-aside designation. The award is placed against the Pharmaceuticals and Drugs Federal Supply Schedule...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $22,438.42 contract is for the drug SIGNIFOR LAR 40 MG and is part of the company's broader Federal Supply Schedule (FSS-61-IB) contract with the VA, valued at $15.6 million, as well as a $3,156,115 Blanket Purchase Agreement covering multiple rare disease treatments. The award has no set-aside...
- The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price delivery order contract to Recordati Rare Diseases Inc., a division of the Recordati Group, for the pharmaceutical product Signifor LAR 40 mg. The contract has a ceiling value of $10,811.24 and an ultimate completion date of November 22, 2024. This delivery order is placed against Recordati's five-year, $15.6 million Federal Supply Schedule (FSS-61-IB) contract with the VA, which allows for the procurement of the company's...